... very "odd" don't ya think that all the fraudster touting of the sarcoma trial is simply stable disease, and as we have no non-fraudster cancer doctors in the house we can't determine whether these results are really just "good".

IMO the failure to acheive any CR's or PR's is a reason this monotherapy approach is being @#$%e canned.

and as i suggested before as this was orphaned by BT (the incompetent) some time ago i am surprised there was any positive price action.

and again here's hoping reo-chemo produces better results for this indication.